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ABSTRACT
A food allergy is defined as “a phenomenon in which adverse reactions are caused through antigen-specific im-
munological mechanisms after exposure to given food.”
Various symptoms of food allergy occur in many organs. Food allergies are classified roughly into 4 clinical
types: (1) neonatal and infantile gastrointestinal allergy, (2) infantile atopic dermatitis associated with food al-
lergy, (3) immediate-type food allergy (urticaria, anaphylaxis, etc.), and (4) food dependent exercise-induced
anaphylaxis and oral allergy syndrome (i.e., specific forms of immediate food allergy).
The therapy for food allergies includes treatment of and prophylactic measures against hypersensitivity such
as anaphylaxis. A fundamental prophylactic measure is the elimination diet. However, elimination diets should
be used only if necessary because of the patient-related burden. For this purpose, it is very important that
causative foods be accurately identified. There are a number of means available to identify causative foods, in-
cluding the history taking, a skin prick test, detection of antigen-specific IgE antibodies in the blood, the baso-
phil histamine release test, the elimination diet test, and the oral challenge test, etc. Of these, the oral challenge
test is the most reliable. However, it should be conducted under the supervision of experienced physicians be-
cause it may cause adverse reactions, such as anaphylaxis.
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1. Definition of a Food Allergy
The Japanese Pediatric Guideline for Food Allergy
2012 (JPGFA2012),1 published by the Japanese Soci-
ety of Pediatric Allergy and Clinical Immunology
(JSPACI) in 2011, provided the following definition:
“a phenomenon in which adverse reactions are
caused through antigen-specific immunological
mechanisms after exposure to given food” (Fig. 1).
2. Clinical Symptoms and Related Diseases
of Food Allergies
2.1. Symptoms of Food Allergies
Food allergy symptoms occur in many organs (Table
1). They are classified into immediate and non-
immediate allergic reactions. The former refers to al-
lergic reactions that develop within 2 hours after food
intake, and the latter refers to those that develop
more than 2 hours after food intake. However, this
differentiation is only based on the elapsed time to
symptom onset and does not necessarily describe a
difference in mechanisms.
Of the symptoms, anaphylaxis is defined as a “se-
vere hypersensitivity reaction that may cause a life-
threatening risk with systemic symptoms induced in
several organs.” Partly because of the fatal nature,
prompt diagnosis and treatment are required.
While the gradeclass2 proposed by Sampson is
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Fig.　1　Defi nition of food allergy. PFS, pollen food allergy syndrome; LFS, latex-fruit syndrome.
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Table　1　Symptoms of food allergies
Organ Symptoms
Skin Erythema, urticaria, angioedema, pruritus, burning sensation, eczema
Mucous membrane Eye symptoms: Conjunctival hyperemia and edema, pruritus, lacrimation, blepharedema
Nasal symptoms: Rhinorrhea, nasal congestion, sneezing
Oral symptoms: Discomfort/swelling of the oral cavity, lips, or tongue
Respiratory organs Discomfort/itch/tightness in the pharyngolarynx, hoarseness, dysphagia, coughing, wheezing, retractive 
breathing, feeling of chest tightness, dyspnea, cyanosis
Digestive organs Nausea, vomiting, abdominal pain, diarrhea, hematochezia
Nerve Headache, lowered vigor, unrest, impaired consciousness
Circulatory organs Decreased blood pressure, tachycardia, bradycardia, arrhythmia, coldness of limbs, pallor (peripheral
circulatory failure)
Systemic Anaphylaxis and anaphylactic shock
used as an indicator for the severity of anaphylactic
symptoms, this guideline presents a version that has
been partially revised (Table 2).
The European Academy of Allergy and Clinical Im-
munology and the American Academy of Allergy,
Asthma & Immunology proposed the combination of
symptoms that are diagnosed as anaphylaxis (Table
3).3,4
Causative agents of anaphylaxis, besides foods, in-
clude medications, blood transfusions, insects, and la-
tex. However, a food allergy is the most common
cause. In Europe and United States, the causative
foods of anaphylaxis include peanuts, nuts and seeds,
seafood, eggs, and cow’s milk. In Japan, the major
causative foods of anaphylaxis include eggs, cow’s
milk, wheat, crustacean, buckwheat, and peanuts.
Food-induced anaphylaxis is an immediate reaction
associated with specific IgE antibodies. Symptoms
typically occur within several minutes after intake.
However, they occasionally occur more than 30 min
later. Symptoms may occur either in a monophasic or
biphasic pattern. Severe anaphylaxis symptoms ac-
companied by decreased blood pressure and im-
paired consciousness are called anaphylactic shock.
Anaphylactic shock likely occurs in patients with food
allergy complicated by asthma.
Decreased blood pressure is caused by a periph-
eral vasodilation and a decrease in the circulating
Food Allergy
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Table　2　Classifi cation of anaphylaxis2
Grade Skin Digestive organ Respiratory organ Circulatory organ Nerve
1 <Localized>
• pruritus, erythe-
ma, urticaria, 
angioedema
• Oral itch and/or 
discomfort
• Swelling of lips
• Pharyngeal pruritus and/or 
discomfort
- -
2 <Systemic>
• pruritus, erythe-
ma, urticaria, 
angioedema
• Nausea
• 1-2 occurrenc-
es of vomiting 
and/or diarrhea
• Transient 
abdominal pain
• Slight nasal congestion 
and/or rhinorrhea
• Sneezing once or twice
• Sporadic coughing
- • Decrease in 
activity level
3 Above symptoms • Repeated 
vomiting, and/
or diarrhea
• Persistent 
abdominal pain
• Marked nasal congestion 
and/or rhinorrhea
• Repeated sneezing
• Persistent cough
• Laryngeal pruritus
• Tachycardia 
(increased ≥15 
beats/minute)
• Sense of 
unease
4 Above symptoms Above symptoms • Laryngeal 
tightness
• Hoarseness
• Barking 
cough
• Dysphagia
• Wheez-
ing
• Dyspnea
• Cyanosis
• Arrhythmia
• Decreased blood 
pressure
• Unrest
• Fear of death
5 Above symptoms Above symptoms • Respiratory 
arrest
• Severe bradycar-
dia
• Marked decrease 
in blood pressure
• Cardiac arrest
• Unconscious-
ness
Not all symptoms are essential. The symptom grade will be determined according to the organ symptoms of the highest grade.
Grade 1 will not be regarded as anaphylaxis.
Table　3　Diagnostic criteria for anaphylaxis4
1. Acute onset of an illness (over minutes to several hours) involving skin, mucosal tissue, or both (e.g., generalized hives, pru-
ritus or fl ushing, swollen lips-tongue-uvula), and at least one of the following:
(1) Respiratory compromise (e.g., dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory fl ow, hypoxemia)
(2) Reduced blood pressure (BP) or associated symptoms of end-organ dysfunction (e.g., hypotonia (collapse), syncope, 
incontinence)
2. Two or more of the following that occur rapidly after exposure to a likely allergen for that patient (minutes to several hours):
(1) Involvement of the skin-mucosal tissue (e.g., generalized hives, itch-fl ush, swollen lips-tongue-uvula)
(2) Respiratory compromise (e.g., dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory fl ow, hypoxemia)
(3) Reduced BP or associated symptoms of end-organ dysfunction (e.g., hypotonia, syncope, incontinence)
(4) Persistent gastrointestinal symptoms (e.g., crampy abdominal pain, vomiting)
3. Reduced BP after exposure to a known allergen for that patient (minutes to several hours). Reduced BP is defi ned:
(1) In adults, as a systolic BP of less than 90 mm Hg or greater than 30 percent decrease from that person’s baseline.
(2) In infants and children, as a low systolic BP (age-specifi c) or greater than 30 percent decrease in systolic BP. Low sys-
tolic BP is defi ned as:
- Less than 70 mm Hg for 1 month to 1 year of age
- Less than (70 mm Hg plus twice the age) for 1 to 10 years of age
- Less than 90 mm Hg for 11 to 17 years of age
Note: In infants and young children, hypotension may be a late manifestation of hypovolemic shock. Tachycardia, in the absence
of hypotension, may also indicate shock.
Symptoms corresponding to any of the above three conditions indicate highly possibly anaphylaxis.
Urisu A et al.
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Table　4　Clinical type of food allergy5
Clinical type Age of onset
Common causative 
foods
Acquisition of 
tolerance
Possibility of 
anaphylactic 
shock
Mechanism of 
food allergy
Neonatal and infantile gastroin-
testinal allergy
Neonatal 
period 
Infancy
Cow’s milk (powdered 
milk for infants)
Mostly remittable (±) Mainly non 
IgE-mediated 
type
Infantile atopic dermatitis 
associated with food allergy†
Infancy Egg, cow’s milk, wheat, 
soybean, etc.
Mostly remittable (+) Mainly IgE-
mediated type
Immediate-type food allergy
(urticaria, anaphylaxis, etc.)
Infancy-
adulthood
Infancy to young child: 
Chicken eggs, cow’s 
milk, wheat, buckwheat, 
fi sh, peanuts, etc.
School-aged children to 
adults: Shellfi sh, fi sh, 
wheat, fruit, buckwheat, 
peanuts, etc.
Chicken eggs, 
cow’s milk, wheat, 
soybeans, etc.
Mostly remittable
Other allergens 
are mostly less 
remittable
(++) IgE-mediated 
type
Specifi c type Food-depen-
dent exercise-
induced 
anaphylaxis 
(FEIAn/FDEIA)
School age-
adulthood
Wheat, shrimp, squid, 
etc.
Less remittable (+++) IgE-mediated 
type
Oral allergy 
syndrome 
(OAS)
Infancy-
adulthood
Fruits, vegetables, etc. Less remittable (±) IgE-mediated 
type
†Some cases are complicated by digestive symptoms, such as chronic diarrhea, and hypoproteinemia. Foods are not involved in all cases
of infantile atopic dermatitis.
plasma volume related to plasma leakage (edema) in
the skin, intestinal tract, or mesentery. In the early
stage, peripheral vasoconstriction and tachycardia
will compensate for the plasma leakage (compen-
sated shock). However, once the compensation be-
comes unsustainable, bradycardia rapidly causes car-
diac arrest. As a result, decreased cerebral blood flow
and hypoxemia result in impaired consciousness.
Hypoxemia is induced by narrowing in the respira-
tory tract, especially in the distal airway from larynx.
Throat tightness, hoarseness, a barking cough,
dysphagia, wheezing, and dyspnea are symptoms that
should not be overlooked in addition to symptoms of
the circulatory organs and neurological system.
3. Clinical Types of Food Allergies
Food allergies are roughly classified into 4 represen-
tative clinical types (Table 4).
3.1. Neonatal and Infantile Gastrointestinal Al-
lergy
Neonatal and infantile gastrointestinal allergy is one
type of food allergy that induces digestive symptoms
such as emesis, hematochezia, and diarrhea in neo-
nates and infants mainly through non-IgE-mediated
(cell-mediated) mechanisms.6,7 A classification of this
type of food allergy has already been proposed in the
United States. However, this classification cannot be
immediately introduced in Japan because there are
many cases in Japan that do not meet this classifica-
tion.8 In light of this situation, the JPGFA2012 tenta-
tively named this disease “neonatal and infantile gas-
trointestinal allergy.”
The most common causative food is cow’s milk.
Others include soybeans and rice. Children who are
exclusively breast-fed may develop this disease.
Allergen-specific lymphocyte stimulation tests are
positive for most patients. This indicates that the al-
lergy is cell-mediated.9
The diagnosis is based on (i) the development of
digestive symptoms after causative food ingestion,
(ii) the disappearance of symptoms by eliminating
causative foods, and (iii) a positive food challenge
test.
The prognosis is favorable. Approximately 70% of
patients acquire tolerance at 1 year of age, and ap-
proximately 90% acquire tolerance by their second
birthday.
3.2. Infantile Atopic Dermatitis Associated with
Food Allergy
Infantile atopic dermatitis associated with food al-
lergy, as a name, was proposed by the study group of
the Ministry of Health, Labour and Welfare. This type
is the most common food allergy during childhood. It
is associated with infantile atopic dermatitis. Eczema
often remits with the elimination of allergen foods.
The food allergy often improves with aging. Common
Food Allergy
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Fig.　2　Number of patients with immediate-type food allergy by age. The number of patients aged 
0-19 years old are shown by age, and the number of patients aged ≥20 years are shown in 10-year 
increments.10
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causative foods include eggs, cow’s milk, wheat, and
soybeans.
3.3. Immediate-type Food Allergy
This type develops immediate symptoms after inges-
tion. Infants may rarely develop immediate symptoms
when they ingest hen’s egg, cow’s milk, wheat, and
other causative foods for the first time. After infancy,
common causative foods are buckwheat, peanuts,
fish, crustacean, and fruit. Tolerance acquisition may
be less common among infants.
3.4. Specific Forms
3.4.1. Food-dependent exercise-induced anaphy-
laxis (FEIAn or FDEIA)
Food-dependent exercise-induced anaphylaxis
(FEIAn) is induced by exercise after food ingestion,
but it does not occur after either food ingestion or ex-
ercise alone. The pathogenesis is IgE-mediated. FE-
IAn is mostly induced by exercise within 2 hours af-
ter food ingestion. It is a relatively rare disease with
the deflection for junior high to high school adoles-
cents.11
Common causative foods are wheat products and
crustacean. FEIAn is mostly induced after high-
intensity exercise. Nonsteroidal anti-inflammatory
drugs, such as aspirin, can exacerbate the condition.
It is desirable to narrow down the causative foods
by history taking and allergy testing, and conduct a
provocation test. No drug has been established that
can prevent FEIAn.
3.4.2. Oral allergy syndrome (OAS)
Oral allergy syndrome (OAS) is an immediate food al-
lergy localized to the mucous membrane via IgE anti-
bodies. Common causative foods are fresh fruit and
vegetables. OAS is often complicated by pollinosis.
OAS complicated by pollinosis is called pollen-
associated food allergy syndrome or pollen-food al-
lergy syndrome (PFS). OAS is established through
sensitization to the pollen allergen protein, and a hy-
persensitivity reaction develops after ingestion of
vegetables or fruit that share cross reactivity with the
pollen allergen protein. A definitive diagnosis can be
made by history taking and identifying antigen-
specific IgE antibodies. A prick-prick test using fresh
vegetables and fruit to identify specific IgE antibodies
is superior to the measurement of antigen-specific
IgE antibodies in the blood. In the oral challenge test
for definitive diagnosis, a fresh food is sublingually
administered.
While an elimination diet is the basis of treatment,
many heat-treated foods can be orally ingested. The
symptoms are alleviated by administration of hista-
mine H1 receptor antagonist. Antigen-specific oral
immunotherapy for pollinosis has also been initiated
to treat OAS. However, a conclusion has not yet been
reached regarding the therapeutic effect.
Urisu A et al.
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Fig.　3　Breakdown of causative foods of immediate-type food allergy (subjects 
are patients who developed symptoms within 60 minutes after food ingestion and 
visited medical institutions).10
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Table　5　Causative foods of immediate-type food allergy by age10
Age group <1 year old 1 year old 2-3 years old
4-6 years 
old
7-19 years 
old
≥20 years 
old Total
Sample size 1270 699 594 454 499 368 3892
First Hen’s egg
62.1%
Hen’s egg
44.6%
Hen’s egg
30.1%
Hen’s egg
23.3%
Crustacean
16.0%
Crustacean
18.0%
Hen’s egg
38.3%
Second Cow’s milk
20.1%
Cow’s milk
15.9%
Cow’s milk
19.7%
Cow’s milk
18.5%
Hen’s egg
15.2%
Wheat
14.8%
Cow’s milk
15.9%
Third Wheat
7.1%
Wheat
7.0%
Wheat
7.7%
Crustacean
9.0%
Buckwheat
10.8%
Fruit
12.8%
Wheat
8.0%
Fourth Fish roe
6.7%
Peanuts
5.2%
Fruit
8.8%
Wheat
9.6%
Fish
11.2%
Crustacean
6.2%
Fifth
Crustacean
Fruit
5.1%
Peanuts
6.2%
Fruit
9.0%
Buckwheat
7.1%
Fruit
6.0%
Sixth Buckwheat
5.9%
Cow’s milk
8.2%
Hen’s egg
6.6%
Buckwheat
4.6%
Seventh Wheat
5.3%
Fish
7.4%
Fish
4.4%
This table lists causative foods that account for >5% in each age group.
4. Diseases Associated with Food Allergies
Urticaria, atopic dermatitis, eosinophilic gastroenteri-
tis, protein-losing enteropathy, celiac disease, and pri-
mary pulmonary hemosiderosis (Heiner syndrome)
complicated with milk allergy have been associated
with ingestion of specific foods, but an immunological
mechanism has not necessarily been established.
When these diseases are diagnosed, the causal rela-
tionship between the ingestion of a specific food and
the disease condition should be analyzed with the in-
volvement of a food allergy taken into consideration.
5. Epidemiology of Food Allergies
On the basis of a large-scale epidemiological survey
in Japan, the prevalence of food allergy is estimated
to be 5-10% in infants, 5% in young children, and 1.5-
3% in schoolchildren. Food allergies are common
Food Allergy
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Fig.　4　Procedure for diagnosis of food allergy (for “Infantile Atopic Dermatitis associated with Food Al-
lergy”).5 SPT, skin prick test.
: SpecialistEmerging symptom (eczema)
Take a detailed case history for
symptoms, time of symptom occurrence after ingestion of suspected food,
age, nutrition, home environment, family allergic history, and drug, etc.
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Improved No change
Continue the above treatments.
Re-evaluate the treatment every 3 months.
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of non-IgE-mediated 
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Recheck case history/blood test
Food elimination/challenge test
Elimination of diagnosed food
Re-education of skin care
Re-evaluation of drug
General blood testing
Specific-IgE test for suspected foods
(SPT, antigen-specific IgE antibody test, etc)
Positive IgE against foods
Refer to specialist
Refer to specialist
Improved
Continue elimination
among infants and young children and significantly
decrease with aging (Fig. 2). This indicates that toler-
ance is mostly likely to be acquired during infancy.
To the best of our knowledge, no epidemiological
survey has been conducted regarding food allergies
among adults. However, given that the rate of adult
patients newly affected by food allergy is not as high
as that in infants and young children and that toler-
ance is less likely to be acquired after school age, the
prevalence among adults is estimated to be similar to
that among school-aged children.
According to the national survey on immediate
food allergy conducted by the Health and Labour Sci-
ences Research in 2001 and 2002, causative foods in-
clude hen’s eggs, cow’s milk, and wheat in that order
(Fig. 3). These 3 foods account for approximately 60%
of all causative foods and are thus considered the 3
major causative foods in Japan. These 3 foods are fol-
lowed by crustacean, fruit, buckwheat, fish, and pea-
nuts. There are age-specific trends for the causative
foods (Table 5). In infants aged <1 year, the above-
mentioned 3 major causative foods (hen’s eggs, cow’s
milk, and wheat) represent approximately 90% of the
total list of causative foods. In children aged 1 year,
the rates of hen’s egg and cow’s milk allergies rapidly
decrease. In contrast, some food allergies increase
with age. In school-aged children, the probability of
crustacean and fruit allergies increases while that for
hen’s egg and cow’s milk allergies decrease. The fre-
quency of wheat allergy remains high for all age
groups. In terms of symptoms, cutaneous symptoms
such as urticaria are the most likely to occur, fol-
lowed by respiratory, mucous membrane, digestive,
and shock symptoms. Shock symptoms are observed
Urisu A et al.
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Fig.　5　Procedure for diagnosis of food allergy (for “Immediate-Type Reaction”).
NSAIDs, non-steroidal anti-infl ammatory drugs; FEIAn, food-dependent exercise-induced 
anaphylaxis; SPT, skin prick test.
†Generally, patients who demonstrate immediate-type reaction in later childhood are less 
likely to acquire tolerance.5
Symptom
Take a detailed case history for
symptoms, time of occurrence of symptom after ingestion of food, age,
nutrition, family history of allergic disease, drug (NSAIDs, β-blocker, etc.)
History taking indicates anaphylaxis (including FEIAn) or 
the causative food cannot be easily anticipated
NO
Negative IgE
Negative
No elimination
Follow-up
3 or more 
Confirm tolerance, food challenge test.†
Elimination of diagnosed food
Below 3
Elimination food positive
Positive IgE
Oral challenge test
General blood tests
IgE measurement of suspected food allergen
(Antigen-specific IgE antibody test, SPT, etc)
YES
Review of laboratory results.
Conduct oral challenge tests, as needed.
Positive
: Specialist
in 10.9% of patients, indicating that immediate food al-
lergy confers a high risk of anaphylactic shock symp-
toms.
6. Diagnosis and Oral Food Challenge Test
Figure 4, 5 provide flowcharts for food allergy diagno-
sis.
6.1. History Taking
Key points in history taking are causative foods and
their intakes, age at symptom onset, reproducibility,
the last time when symptoms occurred, details of the
induced symptoms, time from food ingestion to onset
of symptoms, other causative conditions (exercise,
medication, etc.), past test results, and present inges-
tion of the causative foods. Food diaries are useful for
this purpose.
6.2. Exclusion of Factors Influencing Symptoms,
Other than Diet
Factors other than diet that cause or exacerbate
symptoms should be removed by indoor environ-
mental improvement, proper skin care, and pharma-
cotherapy in subjects with chronic and nonimmediate
symptoms such as atopic dermatitis.
6.3. Skin Test
A skin prick test (SPT) is recommended to determine
the causes of food allergy. Avoid intradermal tests us-
ing food antigens because they are more likely to
yield false positive results and cause anaphylactic re-
actions than the SPT. However, for patients with a
history of symptoms or high antigen-specific IgE anti-
body levels, avoid even the SPT because it may cause
systemic symptoms. Reportedly, an atopy patch test,
in which a food antigen is applied on the skin, is use-
Food Allergy
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Fig.　6　Probability curve of heated chicken egg/cow’s milk allergy and specifi c IgE antibody titers. A. Egg white. B. Cow’s milk.
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ful for predicting nonimmediate reactions in the diag-
nosis of atopic dermatitis. However, no consensus
has been reached on this finding. Before testing, the
use of agents such as antihistamines, antiallergics,
and steroids should be withdrawed because these in-
fluence in vivo tests. While a positive SPT indicates
the presence of antigen-specific IgE antibodies, this
result alone does not substantiate the diagnosis of a
food allergy. However, even if the blood test is nega-
tive for antigen-specific IgE antibodies, a positive SPT
may provide helpful information for the diagnosis of
food allergy. Of note, during early infancy, some pa-
tients negative for antigen-specific IgE antibodies in
the blood may have a positive SPT. Vegetables and
fruit, which cause OAS, are unstable allergens. Thus,
employ a prick-prick test using fresh vegetables and
fruit (skin is pricked with the needle which is pricked
the suspected food). More than 95% of SPT-negative
patients do not present with immediate food allergy.
However, as infants are less responsive to SPT, symp-
toms may be actually induced in infants negative for
SPT.
6.4. Antigen-Specific IgE Antibodies in the Blood
The presence of specific IgE antibody titers suggest
antigen sensitization and do not necessarily indicate
induced symptoms. However, for some antigens
(hen’s eggs, cow’s milk, and peanuts), refer to prob-
ability curves indicating correlations between specific
IgE antibody titers and the positive rates of immedi-
ate reactions in food challenge tests. Furthermore,
some reports suggest specific IgE values, with which
an immediate reaction in oral challenge test is posi-
tive at a probability of 95%.12 However, since the val-
ues differ between reports, they should only be used
as reference values.
6.4.1. Hen’s eggs
Komata et al.13 provided probability curves for egg
white-specific IgE antibody titers by age (Fig. 6). Ac-
cording to those curves, the Class 3 rating of egg
white-specific IgE antibodies at age2 years indicates
that the positive rate in the hen’s egg food challenge
is approximately 70-80%. On the other hand, more
than half of infant patients <1 year old in the Class 2
rating showed positive results in the food challenge,
demonstrating that the positive rate for the same anti-
body titer is higher at a younger age. Ando et al.14 re-
ported that the ovomucoid-specific IgE antibody test
is more useful than the egg white-specific IgE anti-
body test as an indicator for ingestibility of heated
eggs. A part of subjects with hen’s egg allergy in in-
fants may give a negative result of egg white-specific
IgE antibody. In this case, an SPT may be useful for
diagnosis. It has been reported that the higher the
egg white-specific IgE antibody titers, the slower the
acquisition of tolerance against hen’s egg allergy. A
high ovomucoid-specific IgE level also serves as an
indicator for prolonged hen’s egg allergy.
6.4.2. Cow’s milk
Probability curves for cow’s milk-specific IgE anti-
body titers were also reported (Fig. 6). While the
casein-specific IgE antibody titers are superior to
cow’s milk in sensitivity and specificity, β-
lactoglobulin- and α-lactalbumin-specific IgE antibod-
ies are inferior to cow’s milk in both sensitivity and
specificity. SPT is useful for diagnosis of infants with
a negative cow’s milk-specific IgE antibody test but
are still suspected of cow’s milk allergy.
The higher the cow’s milk-specific IgE antibody tit-
ers, the longer the delay in the tolerance acquisition
against the cow’s milk allergy. While the antibody tit-
ers will gradually decrease in subjects acquiring tol-
Urisu A et al.
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Fig.　7　Probability curves of wheat-specifi c and omega-5 gliadin-specifi c IgE antibodies. A. Wheat. B. Omega-5 gliadin.
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erance, the antibody titers will remain high in sub-
jects with delayed tolerance acquisition.
6.4.3. Wheat
Wheat-specific IgE antibody titers are correlated with
positive predictive values in challenge tests. How-
ever, even if titers are >100 UAmL at ages 1 year,
the positive rates are approximately 75%. Antibody tit-
ers which are predicted that positive rates in chal-
lenge tests are95% cannot be calculated (Fig. 7). On
the other hand, omega-5 gliadin-specific IgE antibody
titers show positive predictive values of 90% for Class
3 and almost 100% for Class 4 and above. However,
the diagnostic sensitivity is around 77%; thus, wheat
allergy cannot be ruled out even with negative re-
sults.15,16 However, omega-5 gliadin-specific IgE anti-
body titers are often negative with the acquisition of
tolerance against wheat and are thus useful as a
follow-up indicator.
6.4.4. Buckwheat
It is quite rare that buckwheat allergy clinically cross-
reacts with wheat or rice. Buckwheat-specific IgE an-
tibody titers are primarily high on their own. Con-
versely, if the buckwheat-specific IgE antibody titers
value is similar to that of other cereals, it is less likely
that the patient is allergic to buckwheat.
6.4.5. Soybean
Soybean-specific IgE antibody titers are less sensitive
and specific for the diagnosis of soybean allergy;
therefore, it is important to collect an adequate medi-
cal history and results of an oral challenge test for de-
finitive diagnosis. Soybean allergy associated with
birch pollen sensitization reportedly induces anaphy-
laxis associated with the ingestion of soybean milk,
chiefly among adults, with Gly m 4 (PR-10) function-
ing as an allergen even when soybean-specific IgE an-
tibodies are negative.
6.4.6. Peanuts and nuts
As allergens, peanuts and nuts often induce anaphy-
laxis. A definitive diagnosis of the allergy can be
made when the patient demonstrates a definite his-
tory of symptoms and positive specific IgE antigen tit-
ers. It has been reported in the United States that a
99% positive predictive value is achieved at 13.0 UA
mL for peanuts and 18.5 UAmL for walnuts. In Ja-
pan, however, the positive predictive value may be
slightly lower than that. The Ara h 2 of peanuts has
higher diagnostic accuracy than the crude antigen.17
6.4.7. Crustaceansmollusksshellfish
Clinical symptoms of crustaceanmolluskshellfish
allergy are often typical of an immediate food allergy.
However, the specific IgE antibody titers have insuffi-
cient sensitivity and specificity, and a detailed history
taking regarding the reproducibility of induced symp-
toms and oral challenge test results are essential for
an accurate diagnosis. Approximately 65% of patients
with shrimp allergy also show symptoms with crab.
While mollusks (octopussquid) and shellfish share
tropomyosin as a primary allergen with crustaceans,
the possibility of clinical cross-reactivity is approxi-
mately 20%; therefore, it is recommended that a diag-
nosis be made for each type.
6.4.8. Fish
Because there is a strong cross antigenicity of aller-
gens between fish, the specific IgE antibody titers are
positive in several fish species. However, owing to
poor correlations between the antibody titer levels
and the presence of induced symptoms, the presence
of induced symptoms needs to be confirmed individu-
Food Allergy
Allergology International Vol 63, No3, 2014 www.jsaweb.jp 409
Table　6　Objectives of oral food challenge test
1. Defi nitive diagnosis of a food allergy (identifi cation of the 
causative allergen)
(1) Identifi cation of the causative allergen in the case of an 
immediate reaction after ingestion of several foods
(2) Challenge test to follow the elimination test for atopic 
dermatitis where involvement of a food allergy is sus-
pected
(3) Identifi cation of induced symptoms to foods that have 
been proven of sensitization but have not been ingested
2. Diagnosis of tolerance acquisition
(1) Determination of the time to discontinue an elimination
diet that continued for a period of time after the defi ni-
tive diagnosis of a food allergy
3. Assessment of the risks of induced symptoms
(1) Determine safe intake quantity (ideally conducted at a 
specialized facility)
(2) Assessment of the risks of accidental ingestion for
safety management at kindergartens and schools
ally for each fish species.
6.4.9. Fruit and vegetables
In the case of OAS associated with pollen sensitiza-
tion, some patients may be positive for specific IgE
antibodies of several fruits and vegetables, and others
may be negative for all specific IgE antibodies. In
such a case, a prick-prick test using fresh juice is use-
ful. On the other hand, in a Class 1 fruit allergy that
develops systemic symptoms as a reaction to a single
species of fruit (kiwi fruit, banana, etc.), specific IgE
antibody titers are also mostly positive to the single
species of fruit and are useful for diagnosis.
6.5. Basophil Histamine Release Test
A basophil histamine release test (HRT) is used to
measure the amount of histamine released from pe-
ripheral blood basophils after a reaction to an aller-
gen. This is an in vitro test which most accurately re-
flects specific IgE antibodies in a living body. Clinical
laboratory tests covered by health insurance include
HRT ShionogiⓇ and AllerportⓇ HRT, which use an
automatic analysis system based on the same meas-
urement principle. HRT ShionogiⓇ allows simultane-
ous testing for egg white, cow’s milk, wheat, soybean,
and rice. AllerportⓇ HRT allows for measurement of
18 items, including the foods listed above. HRT
ShionogiⓇ is useful for diagnosis of egg, cow’s milk,
and wheat allergies.18 It is also useful as an ancillary
test for diagnosis of causative foods without chal-
lenge tests in patients who are at a higher risk of se-
vere symptoms. This kit is expected to have higher
specificity than antigen-specific IgE antibody tests for
other foods but sufficient information has not yet
been obtained for clinical assessment.
6.6. Elimination Tests
In an elimination test, the potential causative foods
are eliminated for approximately 2 weeks. Then, ob-
servation of the symptoms is made to determine if
there are improvements. In infants receiving
mother’s milk or mixed feeding, the potential causa-
tive foods are eliminated from the mother’s diet.
6.7. Oral Food Challenge Test
An oral food challenge test is the most reliable for
identifying the causative foods of a food allergy. How-
ever, there is a risk for anaphylaxis; therefore, it is
important to ensure the patient’s safety. Criteria for
facilities are determined to conduct food challenge
tests as healthcare services provided by health insur-
ance. Thus, it is necessary to make a notification ac-
cording to them.
6.7.1. Objectives
The objectives for the oral food challenge test are
provided in Table 6.
6.7.2. Ensuring safety
(1) Conduct the tests under the supervision of physi-
cians and nurses. (2) Prepare agents for emergency,
such as adrenaline (BosminⓇ, Adrenaline SyringeⓇ),
steroids, antihistamines, bronchodilators (inhaled β2
stimulants, aminophylline), and transfusion sets. (3)
Postpone the test if symptoms such as fever or diar-
rhea occur. (4) Start with a small dose and titrate it.
(5) If symptoms occur, discontinue the tests and con-
duct treatment, if needed. If the patient’s background
indicates that severe symptoms are likely to be in-
duced, consider the need for a challenge test and
conduct it only if necessary with appropriate safety
measures. The food challenge tests should be con-
ducted by physicians skilled in the treatment of food
allergies and anaphylaxis. For tests conducted at out-
patient departments or clinics, it is recommended to
prepare for immediate hospitalization.
6.7.3. Preparation
(1) Prepare for tests (staff, equipment, medicines,
etc.), considering the risks of anaphylaxis. (2) Ex-
plain the objectives, methods, risks, and measures for
hypersensitivity and obtain informed written consent.
(3) Before the tests, discontinue the use of agents
that could influence the test results, such as antialler-
gics, histamine H1 receptor antagonists, β2 stimu-
lants, theophylline, oral disodium cromoglycate, Th2
cytokine inhibitors, leukotriene receptor antagonists,
and steroids.
6.7.4. Administration methods
(1) Open test: Both the examiners and the subjects
know the contents of the challenge food. However, if
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the symptoms are subjectives, the test should be per-
formed in a blind manner. (2) Single-blind food chal-
lenge: The examiners know the content of the chal-
lenge food, while the subjects do not. For blinding,
mix the challenge food with masking vehicle, such as
juice, puree, oatmeal, or hamburger. Powdered food
materials may be used as challenge food. The chal-
lenge test is conducted using a placebo (e.g., mask-
ing vehicle alone or a mixture of masking vehicle and
food other than the challenge food) in addition to the
challenge food of interest on different days. (3)
DBPCFC (double-blind placebo-controlled food chal-
lenge test): Both the subjects and examiners who as-
sess the symptoms are blinded to the challenge food.
The challenge food should be prepared by people
(controller) other than examiners. In addition to the
challenge tests using the foods of interest, a test us-
ing a placebo should be conducted on different day.
6.7.5. Protocol for the challenge test
(1) Administration method: Provocation thresholds in
food challenge tests cannot be predicted even when
based on a combination of history and data of various
tests. Therefore, divide the total amount of the chal-
lenge food into 3 to 6 portions and gradually increase
the amount that is administerd. To ensure safety, con-
duct a preliminary challenge test with a small dose. If
negative results are obtained, a challenge test using a
standard dose may be needed on a different day.
(2) Administration intervals and total challenge
dose: Safety can be improved by increasing the ad-
ministration intervals, making it more likely that un-
necessary administration will be avoided before
symptoms develop. Foods are usually given at inter-
vals of 15-30 min because of the time restriction in
challenge tests. Within the scheduled observation pe-
riod, make note of possible indications of symptoms
such as mild redness and small wheals around the
mouth or a mild cough. Make flexible judgments
such as prolonging the observation period or reduc-
ing the dose, as needed. The total challenge dose is
determined as a sufficient amount based on intake
per meal according to age.
(3) Observation period after the last intake: Imme-
diate reactions primarily occur within 1-2 h after in-
take. Thus, even if no symptoms occur, patients
should remain in the hospital for approximately 2 h
after the last intake. Explain to patients that symp-
toms may occur within the following 24 h. Then, in-
struct them about what measures to take before go-
ing home. The rate of nonimmediate reactions in-
duced in a food challenge test varies significantly be-
tween reports. If nonimmediate reactions are pre-
dicted, prolong the observation period, as needed
(e.g., hospitalization for 1 day).
(4) Classification of induced symptoms (Table 2).
7. Prediction, Prophylaxis, and Follow-Up
of Food Allergy
7.1. Prediction of a Food Allergy
Reportedly, a family history of allergy is most useful
for screening of child at high risk for food allergy.
The measurement of the total IgE level in cord blood
is not sensitive enough to predict the development of
allergic diseases and is not recommended for screen-
ing test.
7.2. Prophylaxis for Food Allergies
7.2.1. Effects of maternal food allergen elimina-
tion in late pregnancy
There is no evidence that the incidence of allergic
diseases in childhood is reduced by eliminating food
allergens from the mother’s diet during pregnancy.
Thus, dietary restriction during pregnancy is not rec-
ommended. No significant difference has been ob-
served in the incidence of allergic diseases, total IgE
level in cord blood, or specific IgE level between
mothers who completely eliminated eggs and cow’s
milk and those who did not.
7.2.2. Effects of food allergen elimination in the
mother and child while breastfeeding
There have been many reports indicating that the
elimination of food allergens from the diet of breast-
feeding mothers does not reduce the incidence of al-
lergic diseases after infancy. Thus, dietary restriction
during nursing is not recommended as a prophylactic
measure for food allergy. In some reports, when
mothers and their children undergo dietary restric-
tion during lactation, the incidence of atopic dermati-
tis temporarily declines and there are significant ef-
fects on specific IgE levels. However, these effects
are temporary. In addition, dietary restriction contin-
ued from late gestation through lactation has no per-
sistent prophylactic effects. Instead, it is important to
establish a well-balanced diet.
7.2.3. Cautions with food allergen elimination
There is no evidence that an elimination diet reduces
the incidence of childhood allergic diseases over long
periods. In addition, nutritional deficiencies may oc-
cur if an elimination diet is followed during preg-
nancy, resulting in poor weight gain in pregnant
women and impaired fetal growth. Thus, caution
should be exercised with the use of elimination diets.
Proper nutritional instruction should be provided if
an elimination diet is needed.
The “Support Guide on Lactation and Weaning
2007” of Japan recommends the commencing time of
baby foods approximately 5-6 months after birth. Ad-
vance or delay of this timing is not recommended.
Food Allergy
Allergology International Vol 63, No3, 2014 www.jsaweb.jp 411
Table　7　Labeling of foods containing allergic substances
Specifi c raw materials 
Mandatory Buckwheat, crab, egg, milk, peanut, shrimp, wheat
Recommended Abalone, apple, banana, beef, cashew nut, chicken, gelatin, kiwi fruits, mackerel, matsutake mushroom, 
orange, peach, pork, salmon, salmon roe, sesame, soybean, squid, walnut, yam
From Allergy Labeling Q&A. Available at: http://www.caa.go.jp/foods/pdf/syokuhin12.pdf (in Japanese).
7.3. Natural Course and Allergic March
7.3.1. Natural course
The progression of food allergy is very diverse. Most
patients with food allergy that developed during in-
fancy achieve tolerance as they age. The acquisition
of tolerance in food allergy depends on factors such
as the causative food, age of onset, severity of hyper-
sensitivity, and recognition of allergen ingredients. In
general, tolerance to allergens in hen’s eggs, cow’s
milk, wheat, and soybeans is more likely to be ac-
quired. However, tolerance to allergens in buck-
wheat, peanuts, nuts, crustacean, and fish is less
likely to be acquired. The time to acquire tolerance
for the same food differs significantly between re-
ports, probably owing to differences in allergy sever-
ity in the study patients and the diagnostic tech-
niques that were used. Common factors for delayed
tolerance acquisition include complications with mul-
tiple food allergies, high levels of specific IgE anti-
body titers, past history of anaphylaxis, and complica-
tions with other allergic diseases (e.g., atopic derma-
titis).
The time to tolerance acquisition for each food de-
pends on the allergen proteins recognized by specific
IgE antibodies and antibody binding sites (epitope).
For example, in cases of high levels of ovomucoid-
specific IgE antibodies, hen’s egg allergy is less likely
to spontaneously remit. In addition, specific IgE anti-
bodies in pediatric patients with persistent cow’s milk
allergy primarily recognize a certain epitope.
On the other hand, some infant-onset cases of pea-
nut allergy, for which tolerance is less likely to be ac-
quired, may acquire tolerance. However, the peanut
allergy may recur with later ingestion, if the patient
restricts ingestion after tolerance acquisition.
7.3.2. Food allergy and allergic march
Childhood allergic disease exhibits a natural course,
in which various diseases, such as food allergy, atopic
dermatitis, asthma, and allergic rhinitis, develop with
age. This natural course is called the allergic march.
Food allergy occurs at an early stage. Progression of
the allergic march may be inhibited by alleviating the
sensitization to the food allergen.
8. Management of Food Allergy
8.1. Key Points for Management of Food Allergy
In order to prevent symptoms and ensure safety, the
elimination of causative foods forms the basis of food
allergy treatment. However, this places a burden on
the patients and their family. The minimum amount
of elimination based on the correct identification of
the causative food is important. Prevention of nutri-
tional problems or growth disorders should be care-
fully considered by providing alternative foods and
achieving basic nutritional requirements with the aim
of “eating.”
In addition, it plays an important in improving the
quality of dietary life to consider when and how to
discontinue the elimination diet.
Instruction on social issues such as mental burden
arising from food elimination, food services at nurs-
ery, kindergarten, and school life is also required.
8.2. Basics of Management of Food Allergy
8.2.1. Minimal elimination diet
Minimal food elimination based on the correct identi-
fication of the causative allergen with the aim of “eat-
ing” is fundamental.
(1) Elimination of causative foods: Even foods to be
generally considered as highly allergenic should not
be eliminated for prevention of development of food
allergy.
(2) Reduction in allergenicity by cooking or proc-
essing: Instruct elimination level in accordance with
patient’s tolerance. For example, while raw foods may
cause symptoms, sufficiently heated or processed
foods may not cause symptoms.
(3) Use of hypo-allergenic foods: In infants with
cow’s milk allergy in whom breast milk is not suffi-
cient, a formula free of cow’s milk allergens is essen-
tial.
8.2.2. Consideration of the nutritional aspects
and quality of life through substitution in the
elimination diet
Substitution is easily achieved by use ingenuity in
cooking and providing alternative foods. In order to
maintain quality of life, use foodstuffs that are avail-
able at an ordinary retail shop with reference to aller-
genic substances on food labels, except for a formula
free of cow’s milk allergens.
8.2.3. Dietary instruction and system formation
with the aim of safe ingestion
Ingestion of causative foods should be avoided. If
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Table　8　Key points for diet therapy, listed by food
1. Hen’s egg
Ingestion of several animal/vegetable proteins helps to replace the nutritional contents in hen’s eggs.
For its excellent cooking characteristics, hen’s eggs are frequently used for cooking and food processing.
• Consider cooking ways to eliminate or to substitute hen’s eggs.
Allergenicity will be reduced by heating.
• It should be noted that the reduction in allergenicity of egg white protein may differ according to the cooking conditions.
2. Cow’s milk
Use cow’s milk allergen-free formula as a substitution for cow’s milk-allergic infants.
Instruct nutritional supplementation of calcium. Formula free of cow’s milk allergens is useful for the purpose.
Eliminate processed foods including casein as an additive substance because casein allergenicity is less likely to be reduced 
by heating.
3. Wheat
Use rice as the staple food instead of wheat. Bread and noodles made from rice fl our are also available. Avoid processed 
foods containing gluten.
Wheat allergenicity is less likely to be reduced by heating.
Wheat contained in soy sauce as a raw material will not usually induce symptoms.
Barley tea can be safely drunk by most.
4. Soybean
Miso, soy sauce, and soybean oil are mostly usable for soybean-allergic patients.
A wide variety of soybean foods are available but ingestible foods differ among individuals.
5. Fish
Fish is a major source of Vitamin D and n-3 polyunsaturated fatty acids such as EPA and DHA. These fatty acids inhibit aller-
gic infl ammation. The ways to ingest fi sh should be found.
• Fresh fi sh should be purchased and refreezing at home should be avoided. Increased histamine in preserved fi sh may 
induce toxication associated with urticaria and eruption.
• Soup stock from dried bonito and similar ingredients can be ingested by most.
• Canned fi sh meat can be ingested by most.
6. Crustaceans
The clinical cross-allergenicity between shrimp and crab, which are crustaceans, is high. Whereas the clinical cross-allerge-
nicities between crustaceans and mollusks, such as squid and octopus, and between crustaceans and shellfi sh are low.
7. Meat
It is rare that the elimination of meat is required. Meat should be eliminated only when meat clearly induces symptoms.
Well-heated beef is ingestible by most children who are allergic to cow’s milk.
Elimination of chicken meat is usually unnecessary for children allergic to eggs.
symptoms are induced by a small amount of the anti-
gen in a processed food, accidental ingestion can be
easily avoided by instructing the patient to cook fresh
foodstuffs.
With the aim of preventing health hazards caused
by processed foods containing allergic substances,
the labeling of allergic substances in packed proc-
essed foods was institutionalized in April 2002 by the
Food Sanitation Act. Table 7 shows the items for
which labeling is mandatory (specific raw materials)
and items for which labeling is recommended (quasi-
specific raw materials). It should be noted that the
items for which labeling is recommended are not al-
ways labeled. Instruct patients to check food labels
for processed foods prior to their purchase in order
to prevent accidental ingestion.
8.2.4. Discontinuation of the elimination diet at
an appropriate time in consideration of tolerance
acquisition with age
An elimination diet places a burden on both the
mother and pediatric patient. After the elimination
diet starts, it should not be continued indefinitely but
should be discontinued according to age and severity
of hypersensitivity.
In the case of a less severe infant food allergy, an
elimination diet can be discontinued at the age of 12-
18 months. Indicators for the possibility of discontinu-
ation include a reaction to accidental ingestion, the
presence of antigen-specific IgE antibodies in the
blood and the results of the skin prick test, basophil
histamine release, or oral challenge tests. Of these,
the most reliable test is the oral challenge test.
For foods with a negative result in the oral chal-
lenge test, the possibility of safe ingestion at home
can be examined. In particular, given that atopic der-
matitis may worsen after several days of continuous
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Table　9　Countermeasures for allergy symptoms induced at home, kindergarten, or school
Mild Moderate Severe
Skin symptoms • Localized pruritus and/or 
fl ushing
• Several urticaria areas
• Slightly swollen lips
• Severe pruritus
• Development of fl ushing
• >10 urticaria areas
• Swelling of eyelids and lips
• Generalized severe pruritus, 
fl ushing and/or urticaria
Digestive symptoms • Oral pruritus, uncomfortable 
feeling
• Nausea or 1 occasion of 
vomiting
• Loose stool or 1 occasion of 
diarrhea
• Intermittent abdominal pain
• Repeated vomiting
• Several occasions of diarrhea
• Severe abdominal pain
Respiratory symptoms • Sporadic coughing
• Sneezing
• Intermittent coughing
• Snuffles, rhinorrhea
• Throat pruritus
• Hoarseness, dysphonia
• Continuous hard coughing
• Barking cough
• Wheezing
• Dyspnea
Circulatory symptoms Nil Nil • Tachycardia
• Irregular pulse
• Pallor of the face
• White or purple lips or nails
Neurological symptoms Nil • Sluggishness • Anxiety, fear
• Fatigue
• Confusion
Treatment stages [Stage of careful observation 
with orally administered anti-
histaminics]
[Stage of a medical institution 
visit]
[Stage of an urgent medical in-
stitution visit]
• Follow-up with orally admin-
istered antihistaminics.
• Visit a medical institution 
following administration of 
household medicine for 
emergency (antihistaminics, 
steroid drug, or bronchodila-
tor).
• Administer Epipen® in combi-
nation with antihistaminics,
steroids, or bronchodilator, if 
possible.
• Transfer the patient to a medi-
cal institution by ambulance.
* If symptoms progress, the 
treatment for moderate cas-
es should be applied.
* If symptoms progress, the 
treatment for severe cases 
should be applied.
Points to note 1. Patients and their guardians should carry household medicines for emergency so that the patients 
may administer the drugs while not at home or at kindergarten/school.
2. Consider carrying an Epipen® for patients with a past history of anaphylaxis.
3. If a causative food remains in the mouth, encourage the patient to bring up the food. Then, rinse 
the mouth.
4. If the patient was exposed to the food in the eye, wash the eyes with clean water. Apply a steroid 
eye-drop, if available. Then, visit an ophthalmologist.
5. Anaphylaxis is progressive and may rapidly worsen from the mild symptoms experienced in the 
early stage.
6. If a patient has a previous history of severe symptoms, such as anaphylaxis and shock, treat the 
patient quickly even if the present symptoms are mild.
ingestion, the final decision should be made after eat-
ing the causative food at home.
Even after remission of the allergic reaction, the
pediatric patient may refuse the causative food. Ac-
cordingly, it is less stressful to discontinue the elimi-
nation diet at nursery, kindergarten or school after
confirming that the pediatric patient has come to eat
the causative food normally at home. Table 8 lists the
key points for diet therapy by food.
9. Measures against Symptoms in the
Acute Phase
9.1. Measures for Accidental Ingestion Other
than Medical Institutions
Table 9 lists the symptoms caused by a food-induced
anaphylactic reaction and the measures against them.
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Fig.　8　How to use Epipen®.
Push the cover cap of the
carry case open to take out
the Epipen®. Remove the
blue safety cap to release
the lock.    
Cover cap
After injection, if the orange
needle cover has been
extended, the injection is
complete (the needle is
inside the needle cover).   Orange
needle
cover  
Safety cap
Push the end of the orange needle
cover of the Epipen® firmly on the
anterolateral thigh in a perpendicular
manner until it gives a click and hold
it for several seconds.    
Before use
Extended
After use
Return the used Epipen® to the
carry case, inserting the orange
needle cover first.  
How to use Epipen®
Step 1
Preparation
Step 2
Injection
Step 4
Storage
Step 3
Confirmation
Table　10　Indication of Epipen® for general persons (Japanese Society of Pediatric Allergy and Clinical Immunology-JSPACI)
The Epipen® should be applied to patients suspected of anaphylactic shock, for whom the Epipen® is prescribed, with at least 1 
of the following symptoms:
Digestive symptoms • Repeated vomiting • Persistent severe (intolerable) abdominal pain
Respiratory symptoms • Tightening in the throat or chest
• Persistent severe coughing
• Husky voice
• Breathing with wheeze
• Barking cough
• Difficulty in breathing
Systemic symptoms • Pale lips or nails
• Confusion
• Hardly palpable pulse
• Fatigue
• Incontinence
JSPACI will provide the explanation to patients indicated for Epipen® and their guardians and prepare all guidelines and manuals for nurs-
eries, kindergartens, and schools regarding measures to deal with allergic symptoms and anaphylaxis in accordance with the above.
In the event of accidental ingestion, force the patient
to bring up the accidentally ingested food to minimize
absorption of the antigen(s). If ocular symptoms oc-
cur after rubbing the eyes with hands exposed to
causative foods, wash the eyes and place a drop of an-
tiallergics or steroids in the eyes. In addition, orally
administer household medicines for emergency, pre-
scribed by physicians, such as histamine H1 receptor
antagonists and steroids.
If symptoms are exacerbated or developed in multi-
ple organs, immediately consult a medical institution.
At this time, consider calling an ambulance and using
an adrenaline for self-injectable (EpipenⓇ) (Fig. 8).
An emergency life-saving technician is allowed to use
an EpipenⓇ as part of the duty of care, if it is carried
by the patient. If anaphylactic shock is suspected,
place the patient in the shock posture with the lower
limbs raised approximately 30 degrees. Then, wait for
an ambulance. Provide resuscitation if the patient is
in cardiopulmonary arrest.
9.2. Timing of Adrenaline for Self-Injection and
Instructions for Use
After the use of an adrenaline for self-injection, the
patient should be immediately transported to a doctor
by ambulance. If symptoms do not improve, adrena-
line can be administered again after arrival at the
medical institution. Even after recovery, the patient
needs to be followed up with caution given to the ap-
pearance of a biphasic anaphylactic reaction.
Because adrenaline is a powerful drug with a sud-
den peripheral vasoconstriction activity and vasopres-
sor activity, it cannot be prescribed for patients with
an underlining disease such as diabetes, arterioscle-
rosis, hyperthyroidism, or severe arrhythmia associ-
ated with ventricular tachycardia. Judicious use of
adrenaline is required for patients with hypertension,
pulmonary emphysema, cardiac disease, and elderly
people. The expiry date should be reviewed and
heeded. Re-prescription is recommended until remis-
sion is observed.
The adrenaline for self-injection is produced only
for intramuscular injection into the anterolateral
Food Allergy
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Fig.　9　Treatments to be applied when immediate reaction/anaphylaxis develops.
†If there is a concern about a non-immediate reaction after the treatments in Step 1, orally administer a steroid drug.
‡It should be noted that Solu-Medrol® 40 mg contains lactose.
Mucocutaneous
symptoms 
Digestive
symptoms 
Respiratory
symptoms 
Circulatory/
neurological symptoms
Step 1†
(Grades 1-2) 
Step 2
(Grades 3-4) 
Step 3
(Grade 5) 
x Oral administration of a histamine
  H1 receptor antagonist
x If refractory, another histamine H1
  receptor antagonist should be
  administered. The choice of oral
  administration, intramuscular
  injection, or intravenous injection
  should be based on the severity.       
x Inhale E2 stimulants.
x If SpO2 is <95%, oxygen should be
  administered (in consideration of Step 2).
x If the effects are not adequate, the E2
  stimulants should be repeatedly inhaled.
x If the inhalation is ineffective, immediately
  proceed to Step 2.
x Intramuscularly inject 0.01 mL/kg of 0.1% adrenaline (up to 0.5 mL)
x If refractory, repeat the injection 10-15 minutes later.
x If SpO2 is <95%, administer oxygen. Maintain sufficient oxygen saturation (SpO2). 
x Fluid resuscitation (isotonic solution not containing glucose or potassium). If the patient is in shock, fluid
  should be administered at a minimum dose of 10-20 mL/kg for 10-20 minutes.
x Steroid (slow intravenous injection or intravenous dripping)
x Hydrocortisone 5-10 mg/kg, methylprednisolone ‡or prednisolone 1-2 mg/kg
x Add as needed.
x Dopamine, noradrenaline, and glucagon should be administered to patients with decreased blood 
  pressure that is refractory to adrenaline.
x Intratracheal intubation, artificial mechanical ventilation
x Heart massage/defibrillation (AED)  
Hospitalize the patient immediately.
thigh. In order to prevent an accident, the safety cap
should be kept closed except for when in use.
JSPACI proposed symptoms that are indicators for
the use of EpipenⓇ other than medical staff (Table
10).
9.3. Treatment at a Medical Institution (Fig. 9)
If the effects of adrenaline for self-injection are not
adequate, 0.005-0.01 mgkg of 0.1% adrenaline should
be intramuscularly injected after a lapse of 10-15 min.
If oxygen saturation (SpO2) is <95%, oxygen should
be administered. After vascular access and fluid re-
placement (10-20 mLkg for 10-20 min, more if the
patient is in shock), hydrocortisone (5-10 mgkg)
should be intravenously injected and repeatedly in-
jected at a dose of 5 mgkg every 4-6 hours, as
needed. Methylprednisolone (1-2 mgkg) may also
be intravenously dripped. It should be noted that
Solu-MedrolⓇ 40 contains lactose. Metabolic acidosis
should be corrected. 0.1% adrenaline should be re-
administered, as needed. In patients with urticaria
and vascular edema, antihistamines is administered
intravenously, and in patients with bronchoconstric-
tion, β2 stimulant is inhaled and aminophylline is ad-
ministered intravenously.
10. Antigen-Specific Oral Immunotherapy
10.1. Positioning of Antigen-Specific Oral Immu-
notherapy
Tolerance is more likely to develop for orally adminis-
tered antigens. Antigen-specific oral immunotherapy
has also been initiated to treat food allergy. Elimina-
tion diet is a passive treatment, while this immuno-
therapy is considered to be an active treatment with
the goal of inducing remission of the food allergy.
The clinical effects of oral immunotherapy have been
recognized, but problems with safety remain.
Urisu A et al.
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Table　13　Points to remember in referral to specialists
1. Accurate diagnosis (request of an oral food challenge 
test)
2. Instructions on diets, including elimination and alternative 
diets
3. Instructions on elimination diet, requested by nursery, 
kindergarten, school, etc.
4. Nutrition guidance to discontinue elimination diet and to 
gradually introduce usual diet
5. Instructions on adrenaline (epinephrine) self-injection for
anaphylaxis
10.2. Desensitization and Permanent Oral Toler-
ance
In desensitization, the tolerant status is maintained af-
ter the achievement of the maintenance dose and
while the treatment is continued; however, the toler-
ant status disappears or is attenuated once the treat-
ment is discontinued. In addition, attenuation of the
tolerance occurs in the presence of factors associated
with increased intestinal permeability such as exer-
cise, viral gastrointestinal infectious disease, stress,
or menstruation.
In desensitization, specific IgG4 increases, specific
IgE decreases, and the activation of mast cells and ba-
sophils are attenuated.
In permanent oral tolerance, tolerance is main-
tained even if the maintenance therapy is discontin-
ued. It is unknown if permanent oral tolerance can be
obtained by the currently available oral immunother-
apy for food allergy.
10.3. Future Issues
This therapy is still being investigated, and the devel-
opment of antigens and study on administration
methods for immunotherapy are urgently required
not only in terms of effectiveness but also in terms of
safety. Further, mechanisms for immunotherapy
need to be determined.
11. Measures at Nurseries, Kindergartens,
and Schools
The “Certificate for school life management” (Table
11) is now being used at kindergartens and schools,
and the “Certificate for nursery life management”
(Table 12) is being used at nurseries. On the basis of
the “Research Report on Allergic diseases” published
in 2007, the Ministry of Education, Culture, Sports,
Science and Technology stated that “Measures need
to be taken based on the recognition that allergic dis-
eases are not rare but many children with various al-
lergic diseases are enrolled in schools.” In light of the
above, the “Certificate for school life management
(for allergic diseases)” (hereinafter referred to as the
“Certificate”) (Table 11) was prepared for schools to
advance activities for school children with allergic
diseases, and the “Guideline on Measures for Aller-
gic Diseases at Schools” was prepared to enable kin-
dergartens and schools to cope with food allergies
and anaphylaxis.
In a manner pursuant to the Certificate for school
life management, the “Guideline on Measures against
Allergy at Nursery” and the “Certificate for nursery
life management” (Table 12) were published in
March 2011 by the Ministry of Health, Labour and
Welfare. As a result, kindergartens and schools share
a similar philosophy and methods to deal with aller-
gic symptoms and anaphylaxis.
12. Timing of Referring to Specialists
Table 13 summarizes the timing of referring to a spe-
cialist. In addition to, referring to a specialist is rec-
ommended when there are complications.
Committee for Japanese Pediatric Guide-
line for Food Allergy, Japanese Society of
Pediatric Allergy and Clinical Immunology
Atsuo Urisu, Motohiro Ebisawa, Komei Ito, Yukoh Ai-
hara, Setsuko Ito, Mitsufumi Mayumi, Yoichi Kohno,
Naomi Kondo, Masahiko Arita (Arita Clinic of Pediat-
rics & Pediatric Allergy, Hiroshima), Hideo Kaneko
(Department of Clinical Research, National Hospital
Organization, Nagara Medical Center, Gifu), Hideo
Ogura (Department of Clinical Investigation, Kochi
National Hospital, Kochi), Rumiko Shibata (Depart-
ment of Pediatrics, Fukuoka National Hospital,
Fukuoka), Takayasu Arima (Department of Pediat-
rics, Graduate School of Medicine, Chiba University,
Chiba), Takao Fujisawa (Mie National Hospital, Mie),
Takanori Imai (Department of Pediatrics, Showa Uni-
versity School of Medicine, Tokyo), Mitsuaki Kimura
(Department of Allergy and Clinical Immunology,
Shizuoka Children’s Hospital, Shizuoka), Yasuto
Kondo (Department of Pediatrics, Fujita Health Uni-
versity the Second Teaching Hospital, Aichi),
Kazuyuki Kurihara (Department of Allergy, Kana-
gawa Children’s Medical Center, Kanagawa), Ichiro
Nomura (Division of Allergy, Department of Medical
Subspecialties, National Center for Child Health and
Development, Tokyo), Yusei Ohshima (Department
of Pediatrics, Faculty of Medical Sciences, University
of Fukui, Fukui), Naoki Shimojo (Department of Pe-
diatrics, Graduate School of Medicine, Chiba Univer-
sity, Chiba), Koichi Yamaguchi (Department of Pedi-
atrics, Doai Memorial Hospital, Tokyo, Japan).
REFERENCES
1. Urisu A, Kondo N (reviewers), Food Allergy Committee,
Japanese Society of Pediatric Allergy and Clinical Immu-
nology. [Japanese Pediatric Guideline for Food Allergy
2012]. Tokyo: Kyowa Kikaku, 2011(in Japanese).
2. Sampson HA. Anaphylaxis and emergency treatment. Pe-
diatrics 2003;111:1601-8.
3. Sampson HA, Muñoz-Furlong A, Campbell RL et al. Sec-
Food Allergy
Allergology International Vol 63, No3, 2014 www.jsaweb.jp 419
ond symposium on the definition and management of ana-
phylaxis: summary report-Second National Institute of Al-
lergy and Infectious DiseaseFood Allergy and Anaphy-
lax is Network symposium. J Allergy Clin Immunol 2006;
117:391-7.
4. Muraro A. The management of anaphylaxis in childhood:
position paper of the European Academy of Allergology
and Clinical Immunology. Allergy 2007;62:857-71.
5. Ebisawa M. Management of food allergy in Japan “Food
Allergy Management Guideline 2008 (Revision from
2005)” and “Guidelines for the Treatment of Allergic Dis-
eases in Schools”. Allergol lnt 2009;58:475-83.
6. Nowak-Wegrzyn A, Murano A. Food protein-induced en-
terocolitis syndrome. Curr Opin Allergy Immunol 2009;9:
371-7.
7. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin
Immunol 2010;125:S116-25.
8. Nomura I, Morita H, Hosokawa S et al. Four distinct sub-
types of non-IgE-mediated gastrointestinal food allergies
in neonates and infants, distinguished by their symptoms.
J Allergy Clin Immunol 2011;127:685-8.e1-8.
9. Kimura M, Oh S, Narabayashi S, Taguchi T. Usefulness
of lymphocyte stimulation test for the diagnosis of intesti-
nal cow’s milk allergy in infants. Int Arch Allergy Immunol
2011;157:58-64.
10. Akiyama H, Imai T, Ebisawa M. Japan food allergen label-
ing regulation - history and evaluation. Adv Food Nutr Res
2011;62:139-71.
11. Aihara Y, Takahashi Y, Kotoyori T et al. Frequency of
food-dependent exercise-induced anaphylaxis (FEIAn) in
Japanese junior high school students. J Allergy Clin Im-
munol 2001;108:1035-9.
12. Sampson HA. Utility of food-specific IgE concentrations in
predicting symptomatic food allergy. J Allergy Clin Immu-
nol 2001;107:891-6.
13. Komata T, Soderstrom L, Borres MP, Tachimoto H,
Ebisawa M. The predictive relationship of food-specific
serum IgE concentrations to challenge outcomes for egg
and milk varies by patient age. J Allergy Clin Immunol
2007;119:1272-4.
14. Ando H, Moverare R, Kondo Y et al. Utility of ovomucoid-
specific IgE concentrations in predicting symptomatic
egg allergy. J Allergy Clin Immunol 2008;122:583-8.
15. Ito K, Futamura M, Borres MP et al. IgE antibodies to
omega-5 gliadin associate with immediate symptoms on
oral wheat challenge in Japanese children. Allergy 2008;
63:1536-42.
16. Ebisawa M, Shibata R, Sato S, Borres MP, Ito K. Clinical
utility of IgE antibodies to ω-5 gliadin in the diagnosis of
wheat allergy - a pediatric multicenter challenge study.
Int Arch Allergy Immunol 2012;158:71-6.
17. Dang TD, Tang M, Choo S et al. Increasing the accuracy
of peanut allergy diagnosis by using Ara h 2. J Allergy Clin
Immunol 2012;129:1056-63.
18. Sato S, Tachimoto H, Shukuya A et al. Utility of the pe-
ripheral blood basophil histamine release test in the diag-
nosis of hen’s egg, cow’s milk, and wheat allergy in chil-
dren. Int Arch Allergy Immunol 2011;155 (Suppl 1):96-
103.
